A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
Year: 2000
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Seizure
Authors: T Betts, T Waegemans, P Crawford
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1975668205
